NCT05180240Phase 2Completed

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

Study sponsor: Cardiol Therapeutics Inc. · CRDL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-01-31Actual
Enrollment · participants109Actual
Source updated2026-09-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: extracellular volume (ECV) Measure: Global longitudinal Strain (GLS). After: Measure: Extracellular Volume (ECV) Measure: Global Longitudinal Strain (GLS).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview